Biotechnology firms highlight innovation and pipeline strength as earnings updates reveal evolving trends shaping the sector’s future growth.
U.S. Bancorp USB has been building a steadier growth profile as loan pipelines strengthen and funding costs stabilizes. That combination is showing up in net interest income (NII) and fee-driven ...
Top stories: IMF flags weaker global growth as geopolitical risks intensify; Earnings season lifts big US banks’ profits; Korea markets rebound on foreign inflows.
Biotechnology is the use of biology to solve problems and make useful products. The most prominent approach used is genetic engineering, which enables scientists to tailor an organism’s DNA at will. Why is biotechnology important?
AOL: Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth
Zacks Investment Research on MSN: Legend Biotech (LEGN) moves 18.4% higher: Will this strength last?
24/7 Wall St: Josh Brown: Biotech growth stocks immune to disruption risk
Nasdaq: Sartorius Stedim Biotech FY25 Results Climb; Sees Growth In FY26, Beyond
(RTTNews) - Sartorius Stedim Biotech S.A. (SRTOY, SDMHF, DIM.PA) reported Tuesday higher profit and sales revenues in fiscal 2025, with growth in all regions. Looking ahead for fiscal 2026, the ...
Morningstar: GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to support a portfolio of medicines licensed from China’s Hengrui Pharma.
Likely and unlikely are adjectives. We use them to say that something will probably happen or not happen in the future. We can use them before a noun, or with the verbs be, seem and appear: …
A likely person, place, or thing is one that will probably be suitable for a particular purpose. At one point he had seemed a likely candidate to become Prime Minister. We aimed the microscope at a likely looking target.
He will likely [= probably] be late. It will likely rain tomorrow. This use of likely has sometimes been criticized, but it is very common. It does not occur in highly formal writing.
Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services. [1] . Specialists in the field are known as biotechnologists.
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.
Merriam-webster.com defines Biotechnology as: “ the manipulation (as through genetic engineering) of living organisms or their components to produce useful usually commercial products (such as pest resistant crops, new bacterial strains, or novel pharmaceuticals).”
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by...
Biotechnology, or biotech, is the intersection of biological, engineering and computer sciences, which uses living organisms (or parts of them) and biological systems to create products and services with a wide range of applications.
What Is Biotech? Biotech Definition and Types of Biotech. | Built In
Biotechnology, the design and engineering of biological systems, is the next battlefield of this great-power competition. Biotechnology starts with the cell and provides the tools to reprogram it.
Biotech coverage from Scientific American, featuring news and articles about advances in the field.
Let’s begin with a simple definition: Biotechnology uses living organisms or their components—think DNA and proteins—to solve problems. Biotechnology addresses our largest global challenges in healthcare, agriculture, the environment, and industry.
Legend Biotech Corporation Sponsored ADR (LEGN) shares ended the last trading session 18.4% higher at $25.07. The jump came on an impressive volume with a higher-than-average number of shares changing ...
Kalkine Media: Biotech Momentum Rises As Innovation Trends Meet Dow Jones Futures
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.
Large-cap biotech stocks face patent cliffs and biosimilar competition rather than AI-driven disruption, but companies like Amgen and AbbVie with broad product portfolios and multi-year pipeline ...
Federal Territory of Kuala Lumpur, Malaysia, -- Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) reported a revenue of RM931.69 million for the year ended 31 December 2025, ...
Seeking Alpha: 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood
2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood
The Motley Fool on MSN: Danaher Corp. May Be the Smartest Bet in Biotech Right Now
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...
Biotechnology– the interdisciplinary frontier between biology, engineering, medicine and plant science– is also the scene of exciting scientific and technological developments in many areas of science. Important areas of development include:
Markets Insider: Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
Markets Insider: When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.
Insider Monkey: Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment
Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed that enrollment for its Phase 2 clinical study of EB0 ...
STAT: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM